Feasibility and Benefit of Minimization and Withdrawal of Immunosuppression (IS) Early After Liver Transplantation in HCV Positive Recipients

被引：0
|
作者：
Shaked, A. [1 ]
Feng, S. [2 ]
Punch, J. [3 ]
Reyes, J. [4 ]
Klintmalm, G. [5 ]
Zimmerman, M. [6 ]
DesMarais, M. [2 ]
Kopetskie, H. [7 ]
Priore, A. [8 ]
Bridges, N. [8 ]
Sayre, P. [2 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] UCSF, San Francisco, CA USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Northwestern, Chicago, IL USA
[5] Baylor, Dallas, TX USA
[6] Univ Colorado, Denver, CO 80202 USA
[7] RhoFed, Chapel Hill, NC USA
[8] NIAID, Bethesda, MD 20892 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
2959
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [1] Feasibility and Benefit of Minimization and Withdrawal of Immunosuppression (IS) Early After Liver Transplantation in HCV Positive Recipients.
    Shaked, A.
    Feng, S.
    Punch, J.
    Reyes, J.
    Klintmalm, G.
    Zimmerman, M.
    DesMarais, M.
    Kopetskie, H.
    Priore, A.
    Bridges, N.
    Sayre, P.
    [J]. TRANSPLANTATION, 2014, 98 : 230 - 231
  • [2] Outcomes of immunosuppression minimization and withdrawal early after liver transplantation
    Shaked, Abraham
    DesMarais, Michele R.
    Kopetskie, Heather
    Feng, Sandy
    Punch, Jeffrey D.
    Levitsky, Josh
    Reyes, Jorge
    Klintmalm, Goran B.
    Demetris, Anthony J.
    Burrell, Bryna E.
    Priore, Allison
    Bridges, Nancy D.
    Sayre, Peter H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (05) : 1397 - 1409
  • [3] Fibrosis Progression after Liver Transplantation in HCV Recipients: The Impact of Different Immunosuppression Treatments and Immunosuppression Withdrawal.
    Tariciotti, Laura
    Manzia, Tommaso M.
    Angelico, Roberta
    Toti, Luca
    Fazzolari, Laura
    Anselmo, Alessandro
    Tisone, Giuseppe
    [J]. LIVER TRANSPLANTATION, 2013, 19 : S147 - S147
  • [4] Outcomes of immunosuppression minimization and withdrawal early after liver transplantation (vol 19, pg 1397, 2019)
    Shaked, A.
    DesMarais, M. R.
    Kopetskie, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (08) : 2393 - 2393
  • [5] DCD LIVER TRANSPLANTATION IN HCV POSITIVE RECIPIENTS
    Puneet, Puoni
    Tariciotti, Laura
    Rocha, Chiara
    Buckels, John
    Muiesan, Paolo
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 17 - 17
  • [6] Immunosuppression in HCV-positive liver-transplant recipients
    Chan, Aaron James
    Lake, John R.
    [J]. CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (06) : 648 - 654
  • [7] Immunosuppression and HCV recurrence after liver transplantation
    Samonakis, Dimitrios N.
    Germani, Giacomo
    Burroughs, Andrew K.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (04) : 973 - 983
  • [8] IMMUNOSUPPRESSION IN HCV-RNA POSITIVE LIVER TRANSPLANT RECIPIENTS
    Yaroshenko, Ekaterina B.
    Kornilov, Maxim N.
    Miloserdov, Igor A.
    Moysyuk, Yan G.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 256 - 256
  • [9] Immunosuppression minimization vs. complete drug withdrawal in liver transplantation
    Londono, Maria-Carlota
    Rimola, Antoni
    O'Grady, John
    Sanchez-Fueyo, Alberto
    [J]. JOURNAL OF HEPATOLOGY, 2013, 59 (04) : 872 - 879
  • [10] Hepatitis flares with early prednisolone withdrawal after liver transplantation for HCV.
    Chow, Kai
    Johnston, Peter
    McCall, John
    Munn, Stephen
    [J]. LIVER TRANSPLANTATION, 2007, 13 (06) : S158 - S158
12345